Literature DB >> 30296047

Conformational-Switch Based Strategy Triggered by [18] π Heteroannulenes toward Reduction of Alpha Synuclein Oligomer Toxicity.

Ritobrita Chakraborty1, Sumit Sahoo2, Nyancy Halder2, Harapriya Rath2, Krishnananda Chattopadhyay1.   

Abstract

A water-soluble meso-carboxy aryl substituted [18] heteroannulene (porphyrin) and its Zn-complex have been found to be viable in targeting α-Syn aggregation at all its key microevents, namely, primary nucleation, fibril elongation, and secondary nucleation, by converting the highly heterogeneous and cytotoxic aggresome into a homogeneous population of minimally toxic off-pathway oligomers, that remained unexplored until recently. With the EC50 and dissociation constants in the low micromolar range, these heteroannulenes induce a switch in the secondary structure of toxic prefibrillar on-pathway oligomers of α-Syn, converting them into minimally toxic nonseeding off-pathway oligomers. The inhibition of the aggregation and the reduction of toxicity have been studied in vitro as well as inside neuroblastoma cells.

Entities:  

Keywords:  Heteroannulenes; conformational switch; neuroblastoma cell; off-pathway oligomer; on-pathway oligomer; α-Syn

Mesh:

Substances:

Year:  2018        PMID: 30296047     DOI: 10.1021/acschemneuro.8b00436

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  2 in total

1.  Triphala inhibits alpha-synuclein fibrillization and their interaction study by NMR provides insights into the self-association of the protein.

Authors:  Mandar Bopardikar; Anusri Bhattacharya; Veera Mohana Rao Kakita; Kavitha Rachineni; Lalit C Borde; Sinjan Choudhary; Sri Rama Koti Ainavarapu; Ramakrishna V Hosur
Journal:  RSC Adv       Date:  2019-09-10       Impact factor: 4.036

2.  Role of Tyr-39 for the Structural Features of α-Synuclein and for the Interaction with a Strong Modulator of Its Amyloid Assembly.

Authors:  Oscar Palomino-Hernandez; Fiamma A Buratti; Pamela S Sacco; Giulia Rossetti; Paolo Carloni; Claudio O Fernandez
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.